Dr. Pearlman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Colorado Allergy and Asthma Centers, P.C., ( retired)
125 Rampart Way, Suite 150
Denver, CO 80230Phone+1 303-868-1900- Is this information wrong?
Summary
- Dr. David Pearlman is an allergist/immunologist in Denver, CO area, with a history of of research and teaching at the University of Colorado and subsequent 59 year experience in practice and clinical research in immunology and allergy. He received his medical degree from State University of New York Upstate Medical University.He retired from his practice January 1, 2019. He is Clinical Professor Emeritus, Department of Pediatrics, the University of Colorado School of Medicine.
Education & Training
- National institute of Medical ResearchPost-Doctoral Fellowship, Pharmacology/Physiology, 1963 - 1964
- University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1961 - 1963
- University of ColoradoResidency, Pediatrics, 1960 - 1961
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1958 - 1960
- SUNY Upstate Medical UniversityClass of 1958
- Cornell University3 years, no degree, Biology, 1951 - 1954
Certifications & Licensure
- CO State Medical License Active through 2023
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Allergy & Immunology
Awards, Honors, & Recognition
- Albert Nelson Marquis Lifetime Achievement Award Marquis Who's Who
- David S. Pearlman, M.D. FAAAAI Named Lectureship FAAAI
- Tribute Joint Task Force on Practice Parameters, AAAAI and ACAAI
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsFluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstrictionNeil Martin, John M. Weiler, David S. Pearlman, Loretta Jacques, Carol Nunn, Richard Forth, Sarah West, Karen Dunn, Paul M. O'Byrne> ;The Journal of Asthma. 2020 Apr 1
- Long-term safety and efficacy studies of epinephrine HFA metered-dose inhaler (Primatene® Mist): a two-stage randomized controlled trial.Edward Kerwin, Donald P. Tashkin, Phillip E. Korenblat, Leon S. Greos, David S. Pearlman, George W. Bensch, S. David Miller, Tony Marrs, Mary Z. Luo, Jack Yongfeng Zhang> ;The Journal of Asthma. 2021 May 4
- 11 citationsEfficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6–<12 years)David S. Pearlman, Göran Eckerwall, J. McLaren, Rosa Lamarca, Margareta Puu, Ileen Gilbert, Carin Jorup, Kristina Sandin, Miguel J. Lanz> ;Annals of Allergy, Asthma & Immunology. 2017 Apr 1
- Join now to see all
Press Mentions
- Amid Coronavirus Fears, Startups Rethink the Virtual ConferenceMarch 9th, 2020
Professional Memberships
- Fellow
- American College of Asthma, Allergy and ImmunologyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: